Skip to main contentAI and Advanced
/
METROPOLIS · NSEBSE SENSEX74,517.4+0.24%BSE |
NIFTY 5023,315.05+0.42%NSE |
NIFTY BANK56,206.8-0.15%NSE |
NIFTY IT29,075.9-0.04%NSE |
NIFTY AUTO27,221.15+1.22%NSE |
NIFTY FMCG45,754.8+0.43%NSE |
NIFTY PHARMA26,485.25+1.30%NSE |
NIFTY 50022,680.95+0.66%NSE |
ME
NSE · Equity shares · Healthcare Facilities6.55 · 1.14%
Metropolis Healthcare METROPOLIS
NSE:INR 580
BSE:INR 562.55
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for METROPOLIS
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 573.45
Day rangeINR 557.8 — INR 585
52-week rangeINR 412.25 — INR 609.05
Volume3.69 L
Market cap11,693.78
P/E55.5
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,645.85
Net Income (INR Cr)190.02
Rev Growth (5 Year %)10.52
EPS Growth (5 Year %)0.54
P/E Ratio55.5
EPS9.51
Research path: Interpret Metropolis Healthcare's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
METROPOLISMetropolis Healthcare1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 2,138.05 | 1,867.34 | 1,555.06 |
| Accumulated Depreciation Total | -195.8 | -175.01 | -142.9 |
| Cash Equivalents | 20.65 | 2.97 | 5.96 |
| Other Liabilities Total | 35.59 | 26.8 | 15.8 |
| Accrued Expenses | 28.91 | 19.83 | 21.14 |
| Long Term Debt | 0 | 5.27 | 0 |
| Common Stock Total | 41.47 | 10.36 | 10.25 |
| Other Equity Total | 7.26 | 4.75 | 3.44 |
| Other Current Assets Total | 12.38 | 5.97 | 5.84 |
| Prepaid Expenses | 13 | 9.65 | 7.01 |
| Total Assets | 2,138.05 | 1,867.34 | 1,555.06 |
| Current Portof LT Debt/Capital Leases | 93.65 | 92.07 | 78 |
| Additional Paid-In Capital | 220.16 | 246.19 | 156.58 |
| Cash | 34.18 | 36.58 | 57.01 |
| Total Equity | 1,513.16 | 1,330.97 | 1,096.16 |
| Long Term Investments | 2.18 | 6.99 | 5.95 |
| Retained Earnings(Accumulated Deficit) | 1,244.27 | 1,069.67 | 925.89 |
| Total Common Shares Outstanding | 20.73 | 20.72 | 20.49 |
| Property/Plant/Equipment Total-Gross | 605.82 | 535.53 | 478.94 |
| Tangible Book Valueper Share Common Eq | 15.53 | 11.8 | 12.45 |
| Goodwill Net | 660.25 | 589.88 | 454.68 |
| Total Liabilities | 624.89 | 536.37 | 458.91 |
| Total Debt | 231.91 | 204.13 | 197.06 |
| Short Term Investments | 148.13 | 78.71 | 61.32 |
| Cashand Short Term Investments | 202.96 | 118.26 | 124.29 |
| Total Receivables Net | 173.45 | 157.94 | 135.92 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Deferred Income Tax | 105.63 | 99.51 | 75.05 |
| Accounts Receivable-Trade Net | 170.29 | 148.91 | 126.48 |
| Property/Plant/Equipment Total-Net | 410.01 | 360.52 | 336.03 |
| Minority Interest | 11.39 | 3.67 | 3.12 |
| Total Current Liabilities | 334.02 | 294.33 | 245.87 |
| Total Inventory | 66.82 | 54.12 | 42.78 |
| Accounts Payable | 129.42 | 125.86 | 99.44 |
| Other Currentliabilities Total | 82.05 | 56.58 | 47.3 |
| Total Long Term Debt | 138.27 | 112.06 | 119.07 |
| Intangibles Net | 530.83 | 496.56 | 386.34 |
| Other Long Term Assets Total | 58.59 | 63.58 | 54.05 |
| Note Receivable-Long Term | 7.57 | 3.87 | 2.17 |
| Total Current Assets | 468.61 | 345.94 | 315.83 |
| Capital Lease Obligations | 138.27 | 106.79 | 119.07 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio6.1
Price to Sale Ratio7.11
Growth
Debt 5Yr CAGR %15.61
Margins
Operating Margin 12m16.26
Operating Margin 5y Avg17.54
Net Profit Margin 12m11.86
Net Profit Margin 5y12.55
Yield
Dividend Yield %0.17
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk31.49
Analyst consensus
ConsensusBuy
Consensus score1.94
Analyst opinions18
Strong Sell count0
Sell count2
Hold count2
Buy count7
Strong Buy count7
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,812.9 | 1.27 L | 64.93 | — |
| Max Healthcare Institute | INR 1,075 | 1.05 L | 71.47 | — |
| Fortis Healthcare | INR 935 | 70,588.59 | 67.89 | — |
| Aster DM Healthcare | INR 844.4 | 44,157.18 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,881 | 38,187.34 | 48.07 | — |
Shareholding
Ownership
- Promoter
- 48.86%
- FII
- 11.03%
- MF
- 32.67%
- Other
- 7.44%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Metropolis Healthcare Honoured for Building a Culture of Quality and Scientific Excellence - Business StandardMarket news · 6 Jun 2026, 12:25 am
Metropolis Healthcare Honoured for Building a Culture of Quality and Scientific Excellence Business Standard
METROPOLIS HEALTHCARE LTD Share Price Today - Live METROPOLIS Stock Price for NSE/BSE - UpstoxMarket news · 5 Jun 2026, 12:30 pm
METROPOLIS HEALTHCARE LTD Share Price Today - Live METROPOLIS Stock Price for NSE/BSE Upstox
Metropolis Healthcare schedules analyst meeting for June 08, 2026 - scanx.tradeMarket news · 4 Jun 2026, 8:58 pm
Metropolis Healthcare schedules analyst meeting for June 08, 2026 scanx.trade
Metropolis Healthcare Ltd is Rated Hold by MarketsMOJO - Markets MojoMarket news · 3 Jun 2026, 2:01 am
Metropolis Healthcare Ltd is Rated Hold by MarketsMOJO Markets Mojo
Metropolis Healthcare Ltd Faces Bearish Momentum Amid Technical Downgrade - Markets MojoMarket news · 1 Jun 2026, 12:17 am
Metropolis Healthcare Ltd Faces Bearish Momentum Amid Technical Downgrade Markets Mojo
Metropolis Healthcare Q4 FY26: Robust Profit Surge Masks Valuation Concerns - Markets MojoMarket news · 31 May 2026, 7:28 am
Metropolis Healthcare Q4 FY26: Robust Profit Surge Masks Valuation Concerns Markets Mojo
Corporate actions
Events
- board MeetingsQuarterly Results
- dividendRs.1.0000 per share(50%)Second Interim Dividend
- board MeetingsAudited Results & Interim Dividend
- bonusBonus issue of equity shares in the ratio of 3:1 of Rs. 2/-.
- annual General MeetingPOM
- board MeetingsQuarterly Results & Bonus issue
- dividendRs.4.0000 per share(200%)Interim Dividend
- board MeetingsQuarterly Results & Interim Dividend
Rusaka Markets Community
Discussion and sentiment for Metropolis Healthcare
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Metropolis Healthcare Limited is engaged in providing diagnostic services to patients, healthcare providers, and corporates across India and Africa. It has a single operating segment, namely Pathology services. It is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, other pathological and radiological investigations. Its services include Pathology Testing Services, Corporate Wellness, Lab In Hospitals and Clinical Research Services. It serves a diverse customer base, including B2C (Business to Consumer), B2B (Business to Business), and institutional clients. It offers more than 4,000 tests and profiles, including advanced tests for diagnosing cancer, neurological disorders, infectious diseases, and various genetic abnormalities. Its footprint spans 28 states, seven Union Territories.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- METROPOLIS
- BSE Code
- 542650
Questions
Stock FAQ
What is the symbol and ISIN of Metropolis Healthcare?
Metropolis Healthcare has the symbol METROPOLIS and ISIN - INE112L01020.
What is the current price of Metropolis Healthcare?
Metropolis Healthcare is currently trading at INR 580.00.
What are the year high and year low of Metropolis Healthcare?
Metropolis Healthcare has a year high of INR 609.05 and a year low of INR 412.25.
What is the market capitalization of Metropolis Healthcare?
Metropolis Healthcare has a market capitalization of INR 11,693.78 crore.
What is the P/E ratio of Metropolis Healthcare?
Metropolis Healthcare has a P/E ratio of 55.50.
What is the dividend yield of Metropolis Healthcare?
Metropolis Healthcare has a dividend yield of 0.17%.
How is the financial performance of Metropolis Healthcare based on revenue, net income, and EPS?
Metropolis Healthcare has revenue of INR 1,645.85 crore, net income of INR 190.02 crore, and EPS of INR 10.03.
What is the book value of Metropolis Healthcare?
Metropolis Healthcare has a book value of NA.
What is the debt-to-equity ratio of Metropolis Healthcare?
Metropolis Healthcare has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Metropolis Healthcare?
Metropolis Healthcare has a price-to-book ratio of NA and a price-to-sales ratio of 7.11.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.